Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells

BACKGROUND: Anti-resorptive bisphosphonates (BP) are used for the treatment of osteoporosis and bone metastases. Clinical studies indicated a benefit in survival and tumor relapse in subpopulations of breast cancer patients receiving zoledronic acid, thus stimulating the debate about its anti-tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebert, Regina, Meissner-Weigl, Jutta, Zeck, Sabine, Määttä, Jorma, Auriola, Seppo, Coimbra de Sousa, Sofia, Mentrup, Birgit, Graser, Stephanie, Rachner, Tilman D, Hofbauer, Lorenz C, Jakob, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295226/
https://www.ncbi.nlm.nih.gov/pubmed/25496233
http://dx.doi.org/10.1186/1476-4598-13-265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295226/
https://www.ncbi.nlm.nih.gov/pubmed/25496233
http://dx.doi.org/10.1186/1476-4598-13-265

Ejemplares similares